FDA Inspection 1115999 — ZenRise Clinical Research Pvt., Ltd
The FDA completed an inspection of ZenRise Clinical Research Pvt., Ltd on Oct 25, 2019 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 25, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Bioanalytical BA/BE